Skip to main content
AAN.com
Articles
November 1, 1996

Epidemiologic evidence for a changing natural history of myasthenia gravis

November 1996 issue
47 (5) 1233-1238

Abstract

Objective: To survey the epidemiologic literature for evidence of an increasing prevalence of myasthenia gravis (MG) over time, and to explore the reasons for the increase. Data Sources: We found population-based reports of the epidemiology of MG by searching bibliographic databases. We used MG, epidemiology, prevalence, incidence, and mortality as search terms. Study Selection: We included population-based studies that reported the number of cases and the time period from which rates were calculated. Statistical Methods: We performed a regression analysis of rates versus date of study, comparing the slopes of regression lines for prevalence, incidence, and mortality. We performed a second analysis grouping rates by decade of study and calculating a mean rate weighted by the size of the population studied. We calculated 95% confidence intervals for each rate. Results: We included 33 studies from 1950 through 1995. Prevalence and incidence rates increased over time, but the regression line for prevalence significantly exceeded that for incidence. Mortality rates declined slightly. The weighted means for prevalence rose significantly, but there was no significant change in incidence or mortality. Conclusion: The prevalence of MG has increased over the past forty-five years, probably because patients with the disease have longer life spans owing to present-day treatment.
NEUROLOGY 1996;47: 1233-1238

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Drachman DB. Present and future treatment of myasthenia gravis. N Engl J Med 1987;316:743-745.
2.
Storm-Mathisen A. Epidemiological and prognostical aspects of myasthenia gravis in Norway. Ann NY Acad Sci 1966;135:431-435.
3.
Storm-Mathisen A. Epidemiological and prognostical aspects of myasthenia gravis in Norway [abstract]. Acta Neurol Scand 1976;54:120.
4.
Storm-Mathisen A. Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand 1984;70:274-284.
5.
Giagheddu M, Puggioni G, Sanna G, et al. Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand 1989;79:326-333.
6.
Schoenberg BS. Calculating confidence intervals for rates and ratios: simplified method utilizing tabular values based on the Poisson distribution. Neuroepidemiology 1983;2:257-265.
7.
Garland H, Clark ANG. Myasthenia gravis: a personal study of 60 cases. BMJ 1956;1:1259-1262.
8.
Kurland LT. Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota. J Chronic Dis 1958;8:378-418.
9.
Alter M, Talbert OR, Kurland LT. Myasthenia gravis in a southern community. Arch Neurol 1960;3:399-403.
10.
Pennington GW, Wilson A. Incidence of myasthenia gravis in the Merseyside conurbation. In: Viets HR, ed. Myasthenia gravis. Proceedings of the second international symposium. Springfield, IL: Charles C Thomas, 1961;337-345.
11.
Okinaka S, Reese HH, Katsuki S, et al. The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol Scand 1966;42(suppl 19):68-76.
12.
Gudmundsson KR. The prevalence of some neurological diseases in Iceland. Acta Neurol Scand 1968;44:57-69.
13.
Hokkanen E. Epidemiology of myasthenia gravis in Finland. J Neurol Sci 1969;9:463-478.
14.
Pirskanen R. Genetic aspects in myasthenia gravis: a family study of 264 Finnish patients. Acta Neurol Scand 1977;56:365-388.
15.
Uono M. Clinical statistics of myasthenia gravis in Japan. Int J Neurol 1980;14:87-99.
16.
Oosterhuis HJGH. Myasthenia gravis: a survey. Clin Neurol Neurosurg 1981;83:105-135.
17.
Kuroiwa Y. Epidemioloical aspects of myasthenia gravis in Japan. In: Satoyoshi E, ed. Myasthenia gravis: pathogenesis and treatment. Tokyo: University of Tokyo Press, 1981:9-17.
18.
Araki S, Uchino M, Kumamoto T. Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan. Neuroepidemiology 1987;6:120-129.
19.
Radhakrishnan K, Thacker AK, Maloo JC, Gerryo SE, Mousa ME. Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology 1988;7:159-164.
20.
Kondo K, Takasu T, Ahmed A. Neurological diseases in Karachi, Pakistan: elevated occurrence of subacute sclerosing panencephalitis. Neuroepidemiology 1988;7:66-80.
21.
Oosterhuis HJGH. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-1127.
22.
Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989;80:290-295.
23.
Sorensen TT, Holm E-B. Myasthenia gravis in the county of Viborg, Denmark. Eur Neurol 1989;29:177-179.
24.
Tola MR, Granieri E, Paolino E, et al. Epidemiological study of myasthenia gravis in the province of Ferrara, Italy. J Neurol 1989;236:388-390.
25.
Somer H, Muller K, Kinnunen E. Myasthenia gravis associated with multiple sclerosis: epidemiological survey and immunological findings. J Neurol Sci 1989;89:37-48.
26.
Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis: a longitudinal and comprehensive population survey. Arch Neurol 1991;48:733-739.
27.
Micaglio G, Sartori V, Brazzo F, et al. Epidemiology of myasthenia gravis (MG) in northeast of Italy [abstract]. Neurology 1991;41(suppl 1):243.
28.
D'Alessandro R, Granieri E, Benassi G, et al. Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurol Scand 1991;83:83-88.
29.
Krivopusk ME. Clinico-epidemiological aspects of hereditary neuromuscular diseases in the Krasnodar territory. Zhurnal Nevropat I Psik Imeni S-S-Korsakova 1991;91:3-5.
30.
Ferrari G, Lovaste MG. Epidemiology of myasthenia gravis in the province of Trento (Northern Italy). Neuroepidemiology 1992;11:135-142.
31.
Phillips LH, Torner JC, Anderson MS, Cox GM. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992;42:1888-1893.
32.
Yu YL, Hawkins BR, Ip MS, Wong V, Woo E. Myasthenia gravis in Hong Kong Chinese: 1. epidemiology and adult disease. Acta Neurol Scand 1992;86:113-119.
33.
Christensen PB, Jensen TS, Tsiropoulos I, et al. Incidence and prevalence of myasthenia gravis in western Denmark: 1975-1989. Neurology 1993;43:1779-1783.
34.
Christensen PB, Jensen TS, Tsiropoulos I, et al. Mortality and survival of myasthenia gravis patients in western Denmark 1975-1989 [abstract]. Neurology 1994;44(suppl 2):A193.
35.
Kyriallis K, Hristova AH, Middleton LT. What is the real epidemiology of myasthenia gravis? [abstract] Neurology 1995;45(suppl 4):A351-A352.
36.
Kurland LT, Alter M. Current status of the epidemiology and genetics of myasthenia gravis. In: Viets HR, ed. Myasthenia gravis. Proceedings of the second international symposium. Springfield, IL: Charles C Thomas, 1961:307-336.
37.
Kurtzke JF. Epidemiology of myasthenia gravis. In: Schoenberg BS, ed. Neurological epidemiology: principles and clinical applications, Advances in Neurology, Vol. 19. New York: Raven Press, 1978:545-566.
38.
Treves TA, Rocca WA, Meneghini F. Epidemiology of myasthenia gravis. In: Anderson DW, Schoenberg DG, eds. Neuroepidemiology: a tribute to Bruce Schoenberg. Boston: CRC Press, 1991:297-309.
39.
Phillips LH. The epidemiology of myasthenia gravis. Neurol Clin 1994;12:263-271.

Information & Authors

Information

Published In

Neurology®
Volume 47Number 5November 1996
Pages: 1233-1238
PubMed: 8909435

Publication History

Published online: November 1, 1996
Published in print: November 1996

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Lawrence H. Phillips, II, MD
From the Department of Neurology (Dr. Phillips), University of Virginia, Charlottesville, VA, and the Department of Preventive Medicine and Environmental Health (Dr. Torner), University of Iowa, Iowa City, IA.
Presented in part at the 45th annual meeting of the American Academy of Neurology, New York, NY, April 25-May 1, 1993.
Received December 28, 1994. Accepted in final form March 8, 1996.
Address correspondence and reprint requests to Dr Phillips, Box 394, Department of Neurology, University of Virginia, Charlottesville, VA 22908.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain), Neurología (English Edition), 38, 2, (75-81), (2023).https://doi.org/10.1016/j.nrleng.2020.06.013
    Crossref
  2. Epidemiología de la miastenia gravis en la provincia de Ourense (Galicia, noroeste de España), Neurología, 38, 2, (75-81), (2023).https://doi.org/10.1016/j.nrl.2020.06.011
    Crossref
  3. Epidemiology of myasthenia gravis in France: A retrospective claims database study (STAMINA), Revue Neurologique, (2023).https://doi.org/10.1016/j.neurol.2023.09.004
    Crossref
  4. A propósito de un caso de miastenia gravis visto en nuestro hospital, Neurología, Neurocirugía y Psiquiatría, 50, 1, (26-32), (2022).https://doi.org/10.35366/105547
    Crossref
  5. Myasthenia Gravis and Thymectomy, Journal of Cardiac Critical Care TSS, 05, 03, (229-237), (2022).https://doi.org/10.1055/s-0041-1739528
    Crossref
  6. The epidemiology of myasthenia gravis, Journal of Medicine and Life, 14, 1, (7-16), (2021).https://doi.org/10.25122/jml-2020-0145
    Crossref
  7. The Use of the Saccadometer to Identify Saccadic Characteristics in Myasthenia Gravis: A Pilot Study, Journal of Neuro-Ophthalmology, 42, 1, (e267-e273), (2021).https://doi.org/10.1097/WNO.0000000000001438
    Crossref
  8. Hospital and healthcare insurance system record–based epidemiological study of myasthenia gravis in southern and northern China, Neurological Sciences, 41, 5, (1211-1223), (2020).https://doi.org/10.1007/s10072-019-04146-1
    Crossref
  9. Clinical features of LRP4 /agrin‐antibody–positive myasthenia gravis: A multicenter study , Muscle & Nerve, 62, 3, (333-343), (2020).https://doi.org/10.1002/mus.26985
    Crossref
  10. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study, American Journal of Ophthalmology, 205, (99-105), (2019).https://doi.org/10.1016/j.ajo.2019.04.017
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share